BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19762068)

  • 1. Estrogen receptor immunohistochemistry cutoff value: standardization is needed.
    Arslan C; Dizdar O; Altundag K
    Hum Pathol; 2010 Jan; 41(1):150; author reply 150-1. PubMed ID: 19762068
    [No Abstract]   [Full Text] [Related]  

  • 2. [Behavior of cytosolic tissue polypeptide specific antigen in infiltrating ductal carcinoma of the breast classified as a function of percentage of cells in S phase of the cell cycle].
    Alvarez A; Martínez Rodríguez I; Núñez MI; Ruibal A
    Med Clin (Barc); 1996 Jun; 107(3):116. PubMed ID: 8926755
    [No Abstract]   [Full Text] [Related]  

  • 3. High prevalence of HER-2/neu overexpression among Iranian women with breast cancer: true or false?
    Saatee S; Afrakhteh M; Sadrolhefazi B
    Breast J; 2006; 12(5):499-501. PubMed ID: 16958978
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biological features of breast cancer in patients under 35].
    Damenia AO; Turkevich EA; Semiglazov VF; Kochetova IA; Gurbanov SS; Bit-Sava EM; Efimenko AV
    Vopr Onkol; 2007; 53(6):674-6. PubMed ID: 18416136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors and survival analysis of invasive ductal carcinoma of the breast in Bandung, Indonesia.
    Hernowo BS; Yukawa M; Asaka K; Fujimori T; Maeda S; Mukawi TY
    Kobe J Med Sci; 1995 Aug; 41(4):95-112. PubMed ID: 8904161
    [No Abstract]   [Full Text] [Related]  

  • 6. Luminal B breast tumors are not HER2 positive.
    Bhargava R; Dabbs DJ
    Breast Cancer Res; 2008; 10(5):404; author reply 405. PubMed ID: 18831725
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunohistochemical markers of hormone sensitivity of breast carcinoma].
    Simone G; Paradiso A
    Pathologica; 1992; 84(1094):11-4. PubMed ID: 1300527
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnostic accuracy and prognostic value of core biopsy in the management of breast cancer: a series of 542 patients.
    Richter-Ehrenstein C; Müller S; Noske A; Schneider A
    Int J Surg Pathol; 2009 Aug; 17(4):323-6. PubMed ID: 19029173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of fibroblast growth factor receptor 3 in human breast cancer: correlation with clinicopathological/molecular parameters and prognosis.
    Kuroso K; Imai Y; Kobayashi M; Yanagimoto K; Suzuki T; Kojima M; Ueda Y
    Pathobiology; 2010; 77(5):231-40. PubMed ID: 21116113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is immunohistochemistry less sensitive than quantitative reverse transcriptase polymerase chain reaction for hormone receptor status determination in breast cancer?
    Arnould L; Coudert B; Fumoleau P
    J Clin Oncol; 2009 Jun; 27(16):2733; author reply 2734-5. PubMed ID: 19380432
    [No Abstract]   [Full Text] [Related]  

  • 11. Cancer is heterogeneous.
    Guinebretiere JM
    J Clin Oncol; 2009 Jun; 27(16):2732; author reply 2734-5. PubMed ID: 19380436
    [No Abstract]   [Full Text] [Related]  

  • 12. The estrogen receptors alpha, beta, and beta cx.
    Shaaban AM; Speirs V
    Clin Cancer Res; 2005 Nov; 11(22):8222; author reply 8222-3. PubMed ID: 16299256
    [No Abstract]   [Full Text] [Related]  

  • 13. Pleomorphic ductal carcinoma of the breast with predominant micropapillary features.
    Lenicek T; Szerda F; Demirović A; Mijić A; Kruslin B; Tomas D
    Pathol Int; 2007 Oct; 57(10):694-7. PubMed ID: 17803659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyaluronic acid concentrations in cell membranes are inversely proportional to histological grade and ploidy in infiltrating ductal carcinoma of the breast].
    Ruibal A; Núñez M; Tejerina A
    Rev Esp Med Nucl; 1998; 17(4):310-1. PubMed ID: 9721348
    [No Abstract]   [Full Text] [Related]  

  • 15. Estrogen receptor testing of breast cancer in current clinical practice: what's the question?
    Schnitt SJ
    J Clin Oncol; 2006 Apr; 24(12):1797-9. PubMed ID: 16567766
    [No Abstract]   [Full Text] [Related]  

  • 16. [Significance of estrogen receptor in diagnosis of breast cancers].
    Oyama T; Ishikawa Y; Tagaya N; Horiguchi J
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():74-80. PubMed ID: 17682142
    [No Abstract]   [Full Text] [Related]  

  • 17. Pure or mixed-type invasive lobular carcinoma?
    Bulut N; Dede DS; Sari E; Altundag K
    Hum Pathol; 2008 Jul; 39(7):1121; author reply 1121. PubMed ID: 18570979
    [No Abstract]   [Full Text] [Related]  

  • 18. Rare coexistence of invasive papillary carcinoma with infiltrating ductal carcinoma in male breast: report of a case.
    Bhatia A; Uma Nahar Saikia ; Kumar Y
    Int J Surg Pathol; 2008 Jul; 16(3):311-3. PubMed ID: 18573787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Occult multicentric breast cancer].
    Vtorushin SV; Zab'ialova MV; Glushchenko SA; Perel'muter VM; Slonimskaia EM
    Vopr Onkol; 2009; 55(1):38-41. PubMed ID: 19435197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis of invasive micropapillary carcinoma].
    Fu L
    Zhonghua Bing Li Xue Za Zhi; 2004 Aug; 33(4):305-7. PubMed ID: 15363311
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.